IL132115A0 - Drug preparations for treating sexual dysfunction - Google Patents

Drug preparations for treating sexual dysfunction

Info

Publication number
IL132115A0
IL132115A0 IL13211598A IL13211598A IL132115A0 IL 132115 A0 IL132115 A0 IL 132115A0 IL 13211598 A IL13211598 A IL 13211598A IL 13211598 A IL13211598 A IL 13211598A IL 132115 A0 IL132115 A0 IL 132115A0
Authority
IL
Israel
Prior art keywords
sexual dysfunction
treating sexual
drug preparations
drug
treating
Prior art date
Application number
IL13211598A
Other languages
English (en)
Original Assignee
L A M Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L A M Pharmaceuticals Llc filed Critical L A M Pharmaceuticals Llc
Publication of IL132115A0 publication Critical patent/IL132115A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL13211598A 1997-03-28 1998-03-27 Drug preparations for treating sexual dysfunction IL132115A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/825,121 US5952006A (en) 1995-09-29 1997-03-28 Drug preparations for treating impotency
PCT/US1998/006020 WO1998043614A1 (en) 1997-03-28 1998-03-27 Drug preparations for treating sexual dysfunction

Publications (1)

Publication Number Publication Date
IL132115A0 true IL132115A0 (en) 2001-03-19

Family

ID=25243165

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13211598A IL132115A0 (en) 1997-03-28 1998-03-27 Drug preparations for treating sexual dysfunction

Country Status (11)

Country Link
US (1) US5952006A (de)
EP (1) EP0971694B1 (de)
JP (1) JP2002513410A (de)
AT (1) ATE267583T1 (de)
AU (1) AU750321B2 (de)
CA (1) CA2285181A1 (de)
DE (1) DE69824164T2 (de)
ES (1) ES2222581T3 (de)
IL (1) IL132115A0 (de)
PT (1) PT971694E (de)
WO (1) WO1998043614A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6036977A (en) * 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
US6251436B1 (en) 1995-09-29 2001-06-26 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US6007843A (en) * 1995-09-29 1999-12-28 Lam Pharmaceuticals Corp. Sustained release delivery system
IL141688A0 (en) * 1998-09-04 2002-03-10 Scios Inc Hydrogel compositions for the controlled release administration of growth factors
CA2366903A1 (en) * 1999-04-06 2000-10-12 Zonagen, Inc. Methods for modulating the human sexual response
AU5957600A (en) * 1999-07-30 2001-02-19 Lakefield Minerals Ltd. Pharmaceutical compositions for topical application to treat erectile dysfunction
TWI265925B (en) 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
GR1004266B (el) * 2001-04-30 2003-06-18 Ηλιας Κ. Παπαδοπουλος Φαρμακευτικο παρασκευασμα για την διαγνωση και θεραπεια της στυτικης δυσλειτουργιας
EP3045174A1 (de) * 2003-01-31 2016-07-20 Daiichi Sankyo Company, Limited Medikament zur vorbeugung und behandlung von arteriosklerose und bluthochdruck
EP1608378A1 (de) * 2003-04-02 2005-12-28 Nexmed (Holdings), Inc. Prostaglandin-zusammensetzungen und ihre verwendung zur behandlung von vasospasmus
US7790362B2 (en) * 2003-07-08 2010-09-07 Accumetrics, Inc. Controlled platelet activation to monitor therapy of ADP antagonists
US20070243632A1 (en) 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
FR2877574A1 (fr) * 2004-11-08 2006-05-12 Marie Claude Benattar Utilisation d'acide hyaluronique, eventuellement en association avec au moins un androgene pour le traitement de troubles sexuels ou urinaires feminins par amplification du point g et compositions.
US8703198B2 (en) 2005-03-02 2014-04-22 Aquatrove Biosciences Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof
US20060293236A1 (en) * 2005-06-23 2006-12-28 Prescott Albert G Injectable Osteogenic Formula and Method of Using Same
ES2404939T3 (es) * 2005-06-27 2013-05-29 Daiichi Sankyo Company, Limited Preparación farmacéutica que contiene un antagonista del receptor de la angiotensina II y un bloqueador de los canales de calcio
ITMI20061030A1 (it) 2006-05-26 2007-11-27 Altergon Sa Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica
TWI399223B (zh) * 2006-09-15 2013-06-21 Daiichi Sankyo Co Ltd 奧美沙坦酯及氨氯地平之固體劑型
GB0722507D0 (en) 2007-11-19 2007-12-27 Zhao Xiaobin Hyaluronic acid personal lubricant
US8940794B2 (en) 2011-04-07 2015-01-27 Nexmed Holdings, Inc. Methods and compositions for treating Raynaud's disease
CA2896038C (en) * 2015-07-03 2022-08-09 Glycobiosciences Inc. Polymer matrix compositions comprising a high concentration of bio-fermented sodium hyaluronate and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127118B1 (en) * 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
FR2542616B1 (fr) * 1983-03-17 1987-07-31 Unilever Nv Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
EP0266968A3 (de) * 1986-11-03 1988-08-24 Gérard G. Cohen Gelierte Salbe mit einem Vasodilator
US4829991A (en) * 1987-01-06 1989-05-16 Medical Engineering Corp. Method and device for stimulating an erection
US5219885A (en) * 1987-02-16 1993-06-15 Froelich Juergen Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5017229A (en) * 1990-06-25 1991-05-21 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US5527893A (en) * 1987-09-18 1996-06-18 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
IT1221826B (it) * 1988-06-08 1990-07-12 Medico Harvey Srl Centro Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
CH679670A5 (en) * 1990-10-01 1992-03-31 Applied Pharma Res Commercial carrageenan purificn. - by treatment with hydrogen peroxide in hydrated, inert organic solvent
EP0516026A1 (de) * 1991-05-28 1992-12-02 Takeda Chemical Industries, Ltd. Hydrogel und Verfahren zu seiner Herstellung
WO1993000894A1 (en) * 1991-07-03 1993-01-21 Scott Nathan E Prostaglandin e2 treatment of impotence
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
KR940703666A (ko) * 1991-12-23 1994-12-12 로렌스 티. 웰츠 발기 부전증 치료에 효능있는 약제(a potent drug for treatment of erectile dysfunction)
US5646181A (en) * 1992-07-02 1997-07-08 Research Foundation Of State University Of New York Method and compositions for treating impotence
GR1002418B (el) * 1992-07-29 1996-08-21 Johnson & Johnson Consumer Products Inc. Βιοεπισυναπτομενες συνθεσεις θεραπειας και μεθοδοι χρησης.
AU7244696A (en) * 1995-09-29 1997-04-17 Lam Pharmaceuticals Inc. Sustained release delivery system and long acting narcotic analgesics and antagonists

Also Published As

Publication number Publication date
DE69824164D1 (de) 2004-07-01
AU6588198A (en) 1998-10-22
AU750321B2 (en) 2002-07-18
ES2222581T3 (es) 2005-02-01
PT971694E (pt) 2004-10-29
EP0971694B1 (de) 2004-05-26
DE69824164T2 (de) 2005-07-07
ATE267583T1 (de) 2004-06-15
US5952006A (en) 1999-09-14
EP0971694A1 (de) 2000-01-19
JP2002513410A (ja) 2002-05-08
WO1998043614A1 (en) 1998-10-08
CA2285181A1 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
IL132115A0 (en) Drug preparations for treating sexual dysfunction
GEP20043171B (en) Skin with a Minimal Systemic Effect
ATE304845T1 (de) Hautpflaster enthaltend testosteron und gegebenenfalls estrogen
GR3031897T3 (en) Antifungal nail solution
HU9503605D0 (en) Use of nona- and decapeptides in the preparation of a drug for the treatment of aids
DE69832266D1 (de) Gelträgerstoffe für antiproliferierende mittel
BG101139A (en) Heteroatoms-containing cyclopentanopyridyloxazolidinons
MX9700082A (es) Composicion que consiste de morfina, polipirrolidona y oxido de polialquileno.
MXPA97002401A (es) Agente antiinflamatorio para uso externo.
AU8970198A (en) N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in thetreatment of pain
ZA951880B (en) Transdermal system in the form of a patch comprising a tamoxifen derivative
MY137303A (en) Methods for treating proliferative diseases
EP0683668A4 (de) Präparate und verfahren für eine transdermale arzneistoffverabreichung.
EP0859597A4 (de)
ZA973016B (en) Transdermally administered acetylcysteine as mucolytic agent.
MD798G2 (ro) Metoda de tratament a cancerului mamar
ES2152315T3 (es) Xamoneline tartrato.
HK1046847A1 (en) Pharmaceutical combination with analgesic action containing paracetamol and buspirone.
ZA977895B (en) Transdermal therapeutic system having an active compound combination comprising oestriol.
ES2141044A1 (es) Terapia con oxibutinina.
UA36385A (uk) Спосіб лікування генералізованого пародонтиту
CA2458872A1 (en) Human ubiquitin-conjugating enzyme
MX9702042A (es) Piridinas sustituidas por 2-arilo.
MX9709013A (es) Forma de dosis que comprende oxibutinina.
AU1290797A (en) Topical application of opioid drugs such as morphine for relief of itching and skin disease or irritation